Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRDF - Cardiff Oncology: A High Risk-Reward Opportunity In KRAS-Mutated Cancers

CRDF - Cardiff Oncology: A High Risk-Reward Opportunity In KRAS-Mutated Cancers

Cardiff Oncology Inc.
  • CRDF's onvansertib has better data than both Amgen and Mirati in colorectal cancer.
  • There are a few upcoming catalysts.
  • Cash runway is decent.

For further details see:

Cardiff Oncology: A High Risk-Reward Opportunity In KRAS-Mutated Cancers
Stock Information
Company Name: Cardiff Oncology Inc.
Stock Symbol: CRDF
Market: NASDAQ
Website: cardiffoncology.com
Menu
CRDF CRDF Quote CRDF Short CRDF News CRDF Articles CRDF Message Board
Get CRDF Alerts

News, Short Squeeze, Breakout and More Instantly...